Skip to main content
. 2012 May 12;2(1):6. doi: 10.1007/s13555-012-0006-6

Fig. 2.

Fig. 2

Dermatology Life Quality Index (DLQI) under therapy with adalimumab. The red line shows the falling tendency of DLQI values